National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meeting, 9086 [05-3563]
Download as PDF
9086
Federal Register / Vol. 70, No. 36 / Thursday, February 24, 2005 / Notices
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel, ESLI Intellectual Property RFA.
Date: March 24–25, 2005.
Time: March 24, 2005, 6 p.m. to 9 p.m.
Agenda: To review and evaluate grant
applications.
Place: Double Tree Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Time: March 25, 2005, 8:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Double Tree Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Rudy O. Pozzatti, PhD,
Scientific Review Administrator, Office of
Scientific Review, National Human Genome
Research Institute, National Institutes of
Health, Bethesda, MD 20892, 301–402–0838.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)
Dated: February 16, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–3576 Filed 2–23–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Deafness and
Other Communications Disorders;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Deafness and Other Communications
Disorders Special Emphasis Panel, Protein
Interactions in Auditory and Vestibular
Biology.
Date: March 22, 2005.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: 1400 M Street, NW., Washington,
DC 20005.
VerDate jul<14>2003
18:49 Feb 23, 2005
Jkt 205001
Contact Person: Da-yu Wu, PhD, Scientific
Review Administrator, Scientific Review
Branch, Division of Extramural Activities,
NIDCD, NIH, 6120 Executive Blvd., Suite
400C, Bethesda, MD 20892. 301–496–8683.
wudy@nidcd.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.173, Biological Research
Related to Deafness and Communicative
Disorders, National Institutes of Health, HHS)
Dated: February 16, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–3562 Filed 2–23–05; 8:45 am]
BILLING CODE 4140–01M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel. Review of
Research Scientist Development—Research &
Training (K01), Clinical Investigator—CIA
(K08), Mentored Patient—Oriented Research
Career Development (K23), Mentored
Quantitative Research Career Development
(K25), Conference (R13).
Date: March 15, 2005.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 38, 8600 Rockville Pike, Bethesda,
MD 20892, (Telephone Conference Call).
Contact Person: Eric H. Brown, BS, AB,
MS, Scientific Review Administrator,
National Institute of Arthritis,
Musculoskeletal, and Skin Diseases, National
Institutes of Health, 6701 Democracy Blvd.,
Room 824, MSC 4872, Bethesda, MD 20892–
4874, (301) 435–0815,
browneri@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
Musculoskeletal and Skin diseases Research,
National Institutes of Health, HHS)
Dated: February 16, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–3563 Filed 2–23–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse
and Alcoholism, Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Special
Emphasis Panel, SBIR CONTRACT: Topic
017 Development of Methodology for
Measuring Compliance for Medications.
Date: February 28, 2005.
Time: 10 a.m. to 12:30 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, Fishers
Building—MSC 9304, 5635 Fishers Lane,
3041, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Mahadev Murthy, PhD,
MBA, Scientific Review Administrator,
Extramural Project Review Branch, Office of
Extramural Activities, National Institute of
Alcohol Abuse and Alcoholism, MSC 9304,
Room 3037, Bethesda, MD 20892–9304, (301)
443–0800, mmurthy@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271, Alcohol Research
Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 93.273, Alcohol Research Programs;
93.891, Alcohol Research Center Grants,
National Institutes of Health, HHS)
E:\FR\FM\24FEN1.SGM
24FEN1
Agencies
[Federal Register Volume 70, Number 36 (Thursday, February 24, 2005)]
[Notices]
[Page 9086]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-3563]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and Musculoskeletal and Skin
Diseases; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Arthritis and
Musculoskeletal and Skin Diseases Special Emphasis Panel. Review of
Research Scientist Development--Research & Training (K01), Clinical
Investigator--CIA (K08), Mentored Patient--Oriented Research Career
Development (K23), Mentored Quantitative Research Career Development
(K25), Conference (R13).
Date: March 15, 2005.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Building 38, 8600
Rockville Pike, Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Eric H. Brown, BS, AB, MS, Scientific Review
Administrator, National Institute of Arthritis, Musculoskeletal, and
Skin Diseases, National Institutes of Health, 6701 Democracy Blvd.,
Room 824, MSC 4872, Bethesda, MD 20892-4874, (301) 435-0815,
browneri@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.846,
Arthritis, Musculoskeletal and Skin diseases Research, National
Institutes of Health, HHS)
Dated: February 16, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-3563 Filed 2-23-05; 8:45 am]
BILLING CODE 4140-01-M